{{Rsnum
|rsid=2901964
|Gene=CELA2A
|Chromosome=1
|position=15465931
|Orientation=plus
|GMAF=0.2856
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CELA2A
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 61.6 | 33.9 | 4.5
| HCB | 83.2 | 16.8 | 0.0
| JPT | 82.9 | 15.3 | 1.8
| YRI | 3.4 | 40.1 | 56.5
| ASW | 12.3 | 47.4 | 40.4
| CHB | 83.2 | 16.8 | 0.0
| CHD | 88.1 | 11.9 | 0.0
| GIH | 72.3 | 26.7 | 1.0
| LWK | 8.2 | 43.6 | 48.2
| MEX | 55.2 | 32.8 | 12.1
| MKK | 17.9 | 55.8 | 26.3
| TSI | 73.5 | 24.5 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20932654
|Trait=None
|Title=Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate Cancer
|RiskAllele=
|Pval=0.000005
|OR=5.26
|ORtxt=[NR]
|OA=1
}}

{{on chip | Affy GenomeWide 6}}